Drug Insights

Is Cabtreo approved by the FDA?

7 August 2024
3 min read

Cabtreo, a combination of clindamycin phosphate, adapalene, and benzoyl peroxide, was FDA-approved on October 20, 2023. This approval makes Cabtreo the first triple combination treatment approved for acne.

What is Cabtreo?

Cabtreo is a topical gel that combines three active ingredients to treat acne in adults and children aged 12 and older:

  • Clindamycin phosphate: An antibiotic that targets Cutibacterium acnes, a bacteria associated with acne.
  • Adapalene: A synthetic retinoid that helps restore skin tone and texture and reduces inflammation.
  • Benzoyl peroxide: An oxidizing agent with bactericidal and keratolytic effects.

Cabtreo is designed for use on the skin only and should not be used in the mouth, eyes, or vagina.

How to Use Cabtreo

  • Application: Apply once a day, at the same time each day. Cleanse your face with a mild cleanser, rinse with warm water, and pat dry before application.
  • Dosage: Dispense a pea-sized amount and dot it onto six areas of your face (chin, left/right cheek, nose, left/right forehead). Spread the gel gently over your entire face, avoiding eyes, mouth, and nostrils.
  • Post-application: Wash your hands immediately after applying the gel.

Warnings and Precautions

  • Hypersensitivity: Do not use if you are allergic to clindamycin, adapalene, benzoyl peroxide, or any components of the formulation. Discontinue use if a hypersensitivity reaction occurs.
  • Colon Inflammation: Avoid use if you have a history of colitis or severe diarrhea with past antibiotic use, as clindamycin can cause severe colitis.
  • Photosensitivity: Cabtreo may increase skin sensitivity to sunlight. Avoid excessive sun exposure and use sunscreen and protective clothing.
  • Skin Irritation: May cause redness, scaling, dryness, stinging, or burning. Discontinue use if irritation persists.

Pregnancy and Breastfeeding

  • Pregnancy: The effects of Cabtreo on an unborn baby are unknown. Discuss the risks and benefits with your doctor if you are pregnant or planning to become pregnant.
  • Breastfeeding: It is unknown if Cabtreo passes into breast milk. If used while breastfeeding, apply to the smallest area for the shortest time and avoid application near the nipple.

Side Effects

Common side effects include skin reactions such as:

  • Redness
  • Scaling
  • Dryness
  • Stinging
  • Burning
  • Itching
  • Peeling
  • Swelling

Serious side effects requiring immediate medical attention:

  • Severe allergic reactions (hives, swelling, trouble breathing)
  • Colitis (severe stomach cramps, watery or bloody diarrhea)

Drug Interactions

  • Erythromycin: Do not use Cabtreo with products containing erythromycin.
  • Neuromuscular Blocking Agents: Use with caution.
  • Other Skin Products: May increase skin irritation.

Storage

  • Temperature: Store at room temperature (below 77°F or 25°C).
  • Conditions: Do not freeze. Keep away from heat and store the pump upright.
  • Expiration: Discard any expired product and keep out of reach of children.

Conclusion

Cabtreo, approved by the FDA on October 20, 2023, offers a comprehensive treatment for acne with its triple combination formula. If you are considering Cabtreo, follow your healthcare provider's instructions and be mindful of potential side effects and precautions.

How to obtain the latest development progress of all drugs?

In the Synapse database, you can stay updated on the latest research and development advances of all drugs. This service is accessible anytime and anywhere, with updates available daily or weekly. Use the "Set Alert" function to stay informed. Click on the image below to embark on a brand new journey of drug discovery!

图形用户界面, 文本, 应用程序, 电子邮件

描述已自动生成

图形用户界面, 文本, 应用程序, 电子邮件

描述已自动生成

图形用户界面, 文本, 应用程序, 聊天或短信

描述已自动生成

Eli Lilly's $660 Million Collaboration and Notch Pathway Signal Inhibitors
Hot Spotlight
5 min read
Eli Lilly's $660 Million Collaboration and Notch Pathway Signal Inhibitors
7 August 2024
Eli Lilly currently holds the throne as the world's most valuable pharmaceutical company by market capitalization.
Read →
Is Sitagliptin approved by the FDA?
Drug Insights
3 min read
Is Sitagliptin approved by the FDA?
7 August 2024
Sitagliptin is approved by the U.S. Food and Drug Administration (FDA) for the treatment of type 2 diabetes mellitus in adults. This approval was first granted on October 18, 2006.
Read →
Evorpacept Enhances Tumor Response in HER2+ Gastric Cancer: ALX Oncology's ASPEN-06 Trial
Latest Hotspot
3 min read
Evorpacept Enhances Tumor Response in HER2+ Gastric Cancer: ALX Oncology's ASPEN-06 Trial
7 August 2024
ALX Oncology's Phase 2 ASPEN-06 Trial Shows Evorpacept Enhances Tumor Response in HER2-Positive Gastric Cancer Patients.
Read →
Is Etrasimod approved by the FDA?
Drug Insights
3 min read
Is Etrasimod approved by the FDA?
7 August 2024
etrasimod (Velsipity) is FDA approved. The FDA granted its approval on October 12, 2023. This approval allows for the use of etrasimod in the treatment of adults with moderately to severely active ulcerative colitis.
Read →
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.